Neurology Central

Could an experimental imaging tracer detect inflammation in neurodegenerative diseases?

The Cleveland Clinic Lou Ruvo Center for Brain Health (OH, USA) has obtained the only Investigational New Drug to be issued by the Federal Drug Administration to test the GE180 ligand tracer, an experimental diagnostic imaging tool used to detect neuroinflammation, in the brains of people with Parkinson’s and Alzheimer’s disease.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment